Meta-Analysis
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12330-12340
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12330
Figure 1
Figure 1 Selection of studies.
Figure 2
Figure 2 Meta-analysis of randomized cohort studies comparing the effect of tacrolimus monotherapy on graft acute rejection. Heterogeneity was tested and was found to be not statistically significant (χ2 = 8.58, P = 0.284).
Figure 3
Figure 3 Meta-analysis of andomized cohort studies comparing the effect of tacrolimus monotherapy. A: Drug-related hypertension. Heterogeneity was tested and was found to be not statistically significant (χ2 = 4.21, P = 0.240); B: Cytomegalovirus infection. Heterogeneity was tested and was found to be not statistically significant (χ2 = 1.44, P = 0.696). C: Drug-related diabetes mellitus. Heterogeneity was tested and was found to be not statistically significant (χ2 = 8.10, P = 0.088).
Figure 4
Figure 4 Meta-analysis of andomized cohort studies comparing the effect of tacrolimus monotherapy on hepatitis C virus recurrence. Heterogeneity was tested and was not statistically significant (χ2 = 8.63, P = 0.071).
Figure 5
Figure 5 Meta-analysis of randomized cohort studies comparing the effect of cyclosporine monotherapy. A: Graft rejection. Heterogeneity was tested and was found to be not statistically significant (χ2 = 1.72, P = 0.632); B: Drug-related diabetes mellitus. Heterogeneity was tested and was found to be not statistically significant (χ2 = 1.72, P = 0.697).
Figure 6
Figure 6 Meta-analysis of randomized cohort studies comparing the effect of mycophenolate mofetil monotherapy on acute rejection. Heterogeneity was tested and was found to be not statistically significant (χ2 = 0.13, P = 0.77).